Tanvi H Patel

Researcher

University of Arkansas for Medical Sciences

faculty

4 h-index 13 pubs 45 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Tanvi H Patel's research focuses on hematological malignancies, particularly multiple myeloma, and the immunological aspects of cancer therapies. Recent publications investigate the use of autologous stem cell boosts to mitigate hematotoxicity associated with CAR T-cell therapy in multiple myeloma and explore the role of immune prognostic scores in predicting outcomes for patients treated with bispecific antibodies. Other work includes reviews on HER2 as a biomarker in various cancers and case reports detailing neurological manifestations of multiple myeloma and disseminated encephalomyelitis. Patel also examines the psychological impact of pre-myeloma conditions like monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

With an h-index of 4 and 45 citations across 13 publications, Patel actively collaborates with colleagues at the University of Arkansas for Medical Sciences, including Ramya Bachu, Tanvi Patel, Trilok Shrivastava, and Hira Imad Cheema, with whom they share multiple publications. Their recent activity indicates ongoing engagement in medical research.

Metrics

  • h-index: 4
  • Publications: 13
  • Citations: 45

Selected Publications

  • Case Report: Teclistamab in the treatment of idiopathic immune thrombocytopenia in patients with multiple myeloma (2025) DOI
  • Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP) (2024) DOI
  • Application of Stem Cell Boost for Immune Effector Cell Associated Hematotoxicity (ICAHT) Following BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Multiple Myeloma (MM) (2024) DOI
  • Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma (2024) DOI
  • Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies (2024) DOI
  • Cereblon E3 Ligase Modulators Mezigdomide and Iberdomide in Multiple Myeloma (2024) DOI
  • Exploring T cell subsets as predictors of response to BCMA targeting bispecific antibody therapy in multiple myeloma. (2024) DOI
  • Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma (2024) DOI
  • A Single Center Experience of T Cell Redirecting Therapy Post Stem Cell Transplantation in Relapsed Multiple Myeloma (2024) DOI
  • Amyloid Light-Chain (AL) Amyloidosis of the Trachea Associated With an Indolent B-cell Neoplasm (2024) DOI
  • The Effect of Stem Cell Infusion on Immune Effector Cell Associated Hematotoxicity with BCMA CAR T in Multiple Myeloma (2023) DOI
  • Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma (2023) DOI
  • Necrotizing Enterocolitis in a Patient With Newly Diagnosed Multiple Myeloma and Hyperviscosity Syndrome: A Case Report (2023) DOI
  • Sixth Nerve Palsy From Multiple Myeloma in Central Nervous System: Case Series and Review of Current Literature (2023) DOI
  • A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers (2023) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics